Dear Valued Investor,

We are excited to issue today the following press release titled “Dr. Joel Wallach’s Selenium Research Continues to Benefit Many”.  The research of Youngevity® founder, Dr. Joel D. Wallach, BS, DVM, ND, on Selenium continues to be at the forefront of health and prevention with the recent U.S. Food and Drug Administration (FDA) proposed rule requiring the addition of selenium to the list of required nutrients for infant formula products.

DR. JOEL WALLACH on curing  CYSTIC FIBROSIS  using the trace mineral SELENIUM

As per the FDA document, selenium is an essential nutrient for infants, and formula often serves as a sole source of nutrition for infants.  Selenium will be the 30th mandatory nutrient required in infant formula.  Selenium is an essential trace element for humans that functions largely through an association with proteins known as selenoproteins.  The known biological functions of selenium include defense against oxidative stress, regulation of thyroid hormone action, and regulation of the oxidation/reduction status of vitamin C and other molecules.

Dr. Joel Wallach has been at the front line of Selenium research for nearly 40 years.  In 2003, along with Youngevity®, Dr. Wallach successfully petitioned the FDA to establish a Qualified Health Claim for selenium adding that it “may reduce the risk of certain cancers” to labels of dietary supplements containing Selenium.  Today, Dr. Wallach is renowned for his groundbreaking research on the health benefits of selenium and other minerals.

We are looking forward to sharing more positive news with each of you as the year unfolds.  We are stewards of our shareholders’ investments and take that responsibility very seriously.

Thank you,

John Zervas
Investor Relations
AL International, Inc
Stock Symbol: JCOF
1-800-982-3189 x6509

DR JOEL WALLACH: How Minerals Could Save Your Life